NCT07181148View on ClinicalTrials.gov

A Study to Evaluate the Safety and Effectiveness of MSP01-T for Bowel Cleansing Before a Colonoscopy

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

214

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

May 31, 2026

Conditions
ColonoscopyBowel Preparation
Interventions
DRUG

MSP01-R

Total 20 tablets, split-dose administration over 2 days: 14 tablets the day before colonoscopy, 14 tablets on the morning of colonoscopy, oral intake.

DRUG

MSP01-T

Total 20 tablets, split-dose administration over 2 days: 10 tablets the day before colonoscopy, 10 tablets on the morning of colonoscopy, oral intake.

Trial Locations (1)

Unknown

Kangbuk Samsung Hospital, Seoul

All Listed Sponsors
lead

Mather's Pharm. Co., Ltd.

INDUSTRY

NCT07181148 - A Study to Evaluate the Safety and Effectiveness of MSP01-T for Bowel Cleansing Before a Colonoscopy | Biotech Hunter | Biotech Hunter